4-IPP

Type	HazMat fee for 500 gram (Estimated)
Excepted Quantity	USD 0.00
Limited Quantity	USD 15-60
Inaccessible (Haz class 6.1), Domestic	USD 80+
Inaccessible (Haz class 6.1), International	USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic	USD 100+
Accessible (Haz class 3, 4, 5 or 8), International	USD 200+

Size	Price	US Stock	Global Stock	In Stock
1mg	łËÊ¶ÊÊ	In Stock	In Stock	Login
10mg	łÿÿ¶ÊÊ	In Stock	In Stock	Login
25mg	łîË¶ÊÊ	In Stock	In Stock	Login
50mg	łÇ§ò¶ÊÊ	In Stock	In Stock	Login
100mg	łÇîď¶ÊÊ	In Stock	In Stock	Login
250mg	ł§Ëď¶ÊÊ	In Stock	In Stock	Login

CAS No. :	41270-96-6
Formula :	C₁₀H₇IN₂
M.W :	282.08
SMILES Code :	IC1=NC=NC(C2=CC=CC=C2)=C1
Synonyms :	4-Iodo-6-phenylpyrimidine
MDL No. :	MFCD00234609
InChI Key :	ZTCJXHNJVLUUMR-UHFFFAOYSA-N
Pubchem ID :	817368

GHS Pictogram:
Signal Word:	Danger
Hazard Statements:	H302-H315-H318-H335
Precautionary Statements:	P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P310-P321-P330-P332+P313-P362-P403+P233-P405-P501
Class:	8
UN#:	3261
Packing Group:	Ⅲ

CRC-pc1 and CRC-pc2 organoids	10, 25, 50, 100 μM	24 and 48 hours	Inhibition of the MIF/CD74 signaling axis led to decreased AMPK and AKT phosphorylation, activation of JNK-mediated stress response, resulting in mitochondrial impairment and cell death.	PMC5260021
MM.1S cells	80 μM	24 hours	Enhanced the efficacy of melphalan	PMC5241902
ARP-1 cells	80 μM	24 hours	Downregulated the expression of ITGB5 and ALCAM	PMC5241902
Astrocytes	100 μM	24 hours	To validate the inhibitory effect of MIF inhibitor 4-IPP on COX2 and mPGES-1 expression in astrocytes. Results showed that 4-IPP significantly reduced the protein levels of COX2 and mPGES-1.	PMC6461812
Rat joint capsule fibroblasts	50 μM	24 hours	To validate the inhibitory effect of 4-IPP on MIF-induced TGF-β1 expression, results showed 4-IPP effectively blocked MIF's effect.	PMC8120472
Rat joint capsule fibroblasts	0-2.5 μg/mL	24 hours	To investigate the effect of MIF on TGF-β1 expression, results showed MIF dose-dependently increased TGF-β1 expression.	PMC8120472
RMS cell lines (Rh30, RD, A-204, RMS33-2)	25 µM	24 hours	To evaluate the effect of 4-IPP on RMS cell migration. Results showed that 4-IPP significantly inhibited the migration ability of RMS cells.	PMC11029580
143B cells	10, 20, 40 μM	24, 48, 96 hours	To evaluate the inhibitory effect of 4-IPP on 143B cell proliferation, results showed 4-IPP significantly inhibited cell proliferation	PMC8777168
HOS cells	10, 20, 40 μM	24, 48, 96 hours	To evaluate the inhibitory effect of 4-IPP on HOS cell proliferation, results showed 4-IPP significantly inhibited cell proliferation	PMC8777168
LOVO	30 μM	48 hours	Inhibition of MIF activity, combined with refametinib significantly reduced STAT3 and MAPK activity, synergistically inhibiting cell proliferation	PMC6068346
HCT116	30 μM	48 hours	Inhibition of MIF activity, combined with refametinib significantly reduced STAT3 and MAPK activity, synergistically inhibiting cell proliferation	PMC6068346
HTB-5 cells	30-50 μM	48-72 hours	Evaluate the inhibitory effect of 4-IPP on bladder cancer cell proliferation, results showed 4-IPP is more effective than ISO-1	PMC10031641
HTB-9 cells	30-50 μM	48-72 hours	Evaluate the inhibitory effect of 4-IPP on bladder cancer cell proliferation, results showed 4-IPP is more effective than ISO-1	PMC10031641
PBMCs	50 µM	5 days	To investigate the effect of 4-IPP on T cell proliferation. Results showed that high concentrations of 4-IPP inhibited T cell proliferation.	PMC11029580
HSJD-NB01	5 μM	72 hours	Evaluate the effect of 4-IPP on the viability of HSJD-NB01 cells, results showed that 4-IPP significantly reduced the viability of HSJD-NB01 cells	PMC9206243
IMR5	5 μM	72 hours	Evaluate the effect of 4-IPP on the viability of IMR5 cells, results showed that 4-IPP significantly reduced the viability of IMR5 cells	PMC9206243
SH-SY5Y	5 μM	72 hours	Evaluate the effect of 4-IPP on the viability of SH-SY5Y cells, results showed that 4-IPP significantly reduced the viability of SH-SY5Y cells	PMC9206243
LAN-1	5 μM	72 hours	Evaluate the effect of 4-IPP on the viability of LAN-1 cells, results showed that 4-IPP significantly reduced the viability of LAN-1 cells	PMC9206243
U937 cells	50 μM	72 hours	Evaluated the protective effect of BM cells on AML cells	PMC10978870
HL-60 cells	50 μM	72 hours	Induced apoptosis in AML cells	PMC10978870

CAS No.: 41270-96-6

Alternative Products

Product Details of 4-IPP

Safety of 4-IPP

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

SCID mice	Human MM xenograft model	Intraperitoneal injection	0.5 mg/mouse	Every 3 days for 15 days	4-IPP alone had no therapeutic effect in vivo, but significantly enhanced the effectiveness of melphalan and prolonged mouse survival	PMC5241902
Mice	Nippostrongylus brasiliensis infection model	Intraperitoneal injection	1 mg	Administered every other day during infection	Inhibition of MIF activity resulted in weakened intestinal epithelial responses, including reduced tuft cell hyperplasia and RELM β expression	PMC9705247
Mice	Nippostrongylus brasiliensis infection model	Intraperitoneal injection	1 mg	Every other day during infection	Inhibition of MIF activity resulted in defective intestinal immune responses, including lack of intestinal epithelial tuft cell hyperplasia or upregulation of goblet cell RELM β	PMC9705247
Mice	Heligmosomoides polygyrus infection model	Intraperitoneal injection	1 mg	Every other day, during infection	4-IPP significantly compromised anti-parasite immunity in wild-type mice, showing increased adult worm burdens and egg output.	PMC6821780
Sprague Dawley rats	Post-traumatic joint contracture model	Intra-articular injection	10 μL of 100 mM	Single injection	To study the effect of 4-IPP on joint capsule inflammation and fibrosis, results showed 4-IPP significantly reduced TGF-β1 expression and inflammatory response.	PMC8120472
Male SD rats	Ovalbumin (OVA)-induced asthma model	Intraperitoneal injection	5 mg/kg	Three times a week for 8 weeks	4-IPP treatment significantly reduced the concentrations of Th2-type cytokines IL-5 and IL-13 in lung tissues, attenuated airway resistance, and suppressed bronchial wall thickening, epithelial goblet cell hyperplasia, subepithelial collagen fiber deposition, and bronchial muscularization.	PMC10481618
Nude mice	HOS-derived xenograft model	Intraperitoneal injection	5, 20 mg/kg	Every other day for 3 weeks	To evaluate the inhibitory effect of 4-IPP on tumor growth in vivo, results showed 4-IPP significantly inhibited tumor growth and metastasis	PMC8777168
Sprague-Dawley rats	Spinal cord contusion model	Injection at the lesion site	8 μl of 100 mM	Single injection	To evaluate the effect of 4-IPP on CCL5 expression post-SCI, results showed 4-IPP significantly reduced CCL5 protein levels	PMC6122456
Sprague-Dawley rats	Spinal cord contusion model	Injection at lesion sites	8 μl of 100 mM	Single injection	To evaluate the inhibitory effect of 4-IPP on COX2 and mPGES-1 expression after spinal cord injury. Results showed that 4-IPP significantly reduced the protein levels of COX2 and mPGES-1 and decreased PGE2 production.	PMC6461812
NSG mice	U937.GFP-FFLuc cells systemic engraftment model	Intraperitoneal injection	80 mg/kg	Every other day until the end of the experiment (days 19-23)	Evaluated the effect of 4-IPP on leukemia burden and tumor microenvironment	PMC10978870
Mice	BBN-induced bladder cancer model	Intraperitoneal injection	80 mg/kg	Once daily for 4 weeks	Evaluate the inhibitory effect of 4-IPP on bladder cancer tumor formation, results showed 4-IPP reduced bladder weights and tumor stage	PMC10031641
Nude mice	Neuroblastoma xenograft model	Intraperitoneal injection	80 mg/kg	3 days a week every 2 days for 4 weeks	Evaluate the effect of 4-IPP on tumor growth in neuroblastoma xenograft model, results showed that 4-IPP significantly delayed tumor growth and improved survival	PMC9206243

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	3.55mL 0.71mL 0.35mL	17.73mL 3.55mL 1.77mL	35.45mL 7.09mL 3.55mL
Dissolving Methods	Animal experiment Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1 Protocol 2

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed